The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zuñiga, E.
Right arrow Articles by Gruppi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zuñiga, E.
Right arrow Articles by Gruppi, A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Chagas Disease
The Journal of Immunology, 2002, 168: 3965-3973.
Copyright © 2002 by The American Association of Immunologists

Trypanosoma cruzi Infection Selectively Renders Parasite-Specific IgG+ B Lymphocytes Susceptible to Fas/Fas Ligand-Mediated Fratricide1

Elina Zuñiga*, Claudia C. Motran*, Carolina L. Montes*, Hideo Yagita{dagger} and Adriana Gruppi2,*

* Department of Clinical Biochemistry, Faculty of Chemical Science, National University of Cordoba, Cordoba, Argentina; and {dagger} Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan

The control of B cell expansion has been thought to be solely regulated by T lymphocytes. We show in this study that Trypanosoma cruzi infection induces up-regulation of both Fas and Fas ligand (FasL) molecules on B cells and renders them susceptible to B cell-B cell killing (referred to as fratricide throughout this paper) mediated via Fas/FasL. Moreover, by in vivo administration of anti-FasL blocking mAb we demonstrate that Fas-mediated B cell apoptosis is an ongoing process during this parasitic infection. We also provide evidence that B cells that have switched to IgG isotype are the preferential targets of B cell fratricide. More strikingly, this death pathway selectively affects IgG+ B cells reactive to parasite but not self Ags. Parasite-specific but not self-reactive B cells triggered during this response are rescued after either in vitro or in vivo FasL blockade. Fratricide among parasite-specific IgG+ B lymphocytes could impair the immune control of T. cruzi and possibly other chronic protozoan parasites. Our results raise the possibility that the blockade of Fas/FasL interaction in the B cell compartment of T. cruzi-infected mice may provide a means for enhancing antiparasitic humoral immune response without affecting host tolerance.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
N. Antoine-Moussiaux, P. Buscher, and D. Desmecht
Host-Parasite Interactions in Trypanosomiasis: on the Way to an Antidisease Strategy
Infect. Immun., April 1, 2009; 77(4): 1276 - 1284.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. V. C. Guillermo, E. M. Silva, F. L. Ribeiro-Gomes, J. De Meis, W. F. Pereira, H. Yagita, G. A. DosReis, and M. F. Lopes
The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection
J. Leukoc. Biol., April 1, 2007; 81(4): 942 - 951.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Bonardelle, K. Benihoud, N. Kiger, and P. Bobe
B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice
J. Leukoc. Biol., November 1, 2005; 78(5): 1052 - 1059.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. V. Acosta Rodriguez, E. Zuniga, C. L. Montes, and A. Gruppi
Interleukin-4 biases differentiation of B cells from Trypanosoma cruzi-infected mice and restrains their fratricide: role of Fas ligand down-regulation and MHC class II-transactivator up-regulation
J. Leukoc. Biol., January 1, 2003; 73(1): 127 - 136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.